ID   NR1H2_RAT               Reviewed;         446 AA.
AC   Q62755; Q62694;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JUL-2024, entry version 184.
DE   RecName: Full=Oxysterols receptor LXR-beta;
DE   AltName: Full=Liver X receptor beta;
DE   AltName: Full=Nuclear receptor subfamily 1 group H member 2;
DE   AltName: Full=Orphan nuclear receptor OR-1;
DE   AltName: Full=Ubiquitously-expressed nuclear receptor;
DE            Short=UR;
GN   Name=Nr1h2; Synonyms=Lxrb;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=7892230; DOI=10.1073/pnas.92.6.2096;
RA   Teboul M., Enmark E., Li Q., Wikstroem A.-C., Pelto-Huikko M.,
RA   Gustafsson J.-A.;
RT   "OR-1, a member of the nuclear receptor superfamily that interacts with the
RT   9-cis-retinoic acid receptor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:2096-2100(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Vagina;
RX   PubMed=7971966; DOI=10.1073/pnas.91.23.10809;
RA   Song C., Kokontis J.M., Hiipakka R.A., Liao S.;
RT   "Ubiquitous receptor: a receptor that modulates gene activation by retinoic
RT   acid and thyroid hormone receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:10809-10813(1994).
CC   -!- FUNCTION: Nuclear receptor that exhibits a ligand-dependent
CC       transcriptional activation activity (By similarity). Binds
CC       preferentially to double-stranded oligonucleotide direct repeats having
CC       the consensus half-site sequence 5'-AGGTCA-3' and 4-nt spacing (DR-4).
CC       Regulates cholesterol uptake through MYLIP-dependent ubiquitination of
CC       LDLR, VLDLR and LRP8; DLDLR and LRP8. Interplays functionally with RORA
CC       for the regulation of genes involved in liver metabolism (By
CC       similarity). Induces LPCAT3-dependent phospholipid remodeling in
CC       endoplasmic reticulum (ER) membranes of hepatocytes, driving SREBF1
CC       processing and lipogenesis (By similarity). Via LPCAT3, triggers the
CC       incorporation of arachidonate into phosphatidylcholines of ER
CC       membranes, increasing membrane dynamics and enabling triacylglycerols
CC       transfer to nascent very low-density lipoprotein (VLDL) particles. Via
CC       LPCAT3 also counteracts lipid-induced ER stress response and
CC       inflammation, likely by modulating SRC kinase membrane
CC       compartmentalization and limiting the synthesis of lipid inflammatory
CC       mediators (By similarity). Plays an anti-inflammatory role during the
CC       hepatic acute phase response by acting as a corepressor: inhibits the
CC       hepatic acute phase response by preventing dissociation of the N-Cor
CC       corepressor complex (By similarity). {ECO:0000250|UniProtKB:P55055,
CC       ECO:0000250|UniProtKB:Q60644}.
CC   -!- SUBUNIT: Forms a heterodimer with RXR. Interacts with CCAR2 (via N-
CC       terminus) in a ligand-independent manner. Interacts (when sumoylated)
CC       with GPS2; interaction with GPS2 onto hepatic acute phase protein
CC       promoters prevents N-Cor corepressor complex dissociation (By
CC       similarity). Interacts with ABCA12 and ABCA1; this interaction is
CC       required for ABCA1 localization to the cell surface and is necessary
CC       for its normal activity and stability (By similarity).
CC       {ECO:0000250|UniProtKB:P55055}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00407}.
CC   -!- PTM: Sumoylated by SUMO2 at Lys-395 and Lys-433 during the hepatic
CC       acute phase response, leading to promote interaction with GPS2 and
CC       prevent N-Cor corepressor complex dissociation.
CC       {ECO:0000250|UniProtKB:P55055}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR1
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U20389; AAA69522.1; -; mRNA.
DR   EMBL; U14533; AAA52361.1; -; mRNA.
DR   PIR; I59354; I59354.
DR   RefSeq; NP_113814.1; NM_031626.1.
DR   AlphaFoldDB; Q62755; -.
DR   SMR; Q62755; -.
DR   STRING; 10116.ENSRNOP00000026862; -.
DR   BindingDB; Q62755; -.
DR   ChEMBL; CHEMBL4105785; -.
DR   PhosphoSitePlus; Q62755; -.
DR   PaxDb; 10116-ENSRNOP00000026862; -.
DR   Ensembl; ENSRNOT00055008873; ENSRNOP00055006742; ENSRNOG00055005528.
DR   Ensembl; ENSRNOT00060011864; ENSRNOP00060008928; ENSRNOG00060007205.
DR   Ensembl; ENSRNOT00065047610; ENSRNOP00065039051; ENSRNOG00065027607.
DR   GeneID; 58851; -.
DR   KEGG; rno:58851; -.
DR   UCSC; RGD:61906; rat.
DR   AGR; RGD:61906; -.
DR   CTD; 7376; -.
DR   RGD; 61906; Nr1h2.
DR   VEuPathDB; HostDB:ENSRNOG00000019812; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   HOGENOM; CLU_007368_12_4_1; -.
DR   InParanoid; Q62755; -.
DR   OrthoDB; 5390715at2759; -.
DR   PhylomeDB; Q62755; -.
DR   TreeFam; TF352167; -.
DR   Reactome; R-RNO-383280; Nuclear Receptor transcription pathway.
DR   Reactome; R-RNO-4090294; SUMOylation of intracellular receptors.
DR   Reactome; R-RNO-8866427; VLDLR internalisation and degradation.
DR   Reactome; R-RNO-9029569; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux.
DR   Reactome; R-RNO-9623433; NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis.
DR   PRO; PR:Q62755; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000019812; Expressed in thymus and 20 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0034191; F:apolipoprotein A-I receptor binding; ISO:RGD.
DR   GO; GO:0051117; F:ATPase binding; ISO:RGD.
DR   GO; GO:0031490; F:chromatin DNA binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISO:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IDA:RGD.
DR   GO; GO:0004879; F:nuclear receptor activity; ISO:RGD.
DR   GO; GO:0046965; F:nuclear retinoid X receptor binding; IDA:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IMP:NTNU_SB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0044255; P:cellular lipid metabolic process; ISO:RGD.
DR   GO; GO:0042632; P:cholesterol homeostasis; ISS:UniProtKB.
DR   GO; GO:0055088; P:lipid homeostasis; ISO:RGD.
DR   GO; GO:0010887; P:negative regulation of cholesterol storage; ISO:RGD.
DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; IDA:RGD.
DR   GO; GO:0032369; P:negative regulation of lipid transport; ISO:RGD.
DR   GO; GO:0048550; P:negative regulation of pinocytosis; ISO:RGD.
DR   GO; GO:0045861; P:negative regulation of proteolysis; ISO:RGD.
DR   GO; GO:1903573; P:negative regulation of response to endoplasmic reticulum stress; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0036151; P:phosphatidylcholine acyl-chain remodeling; ISS:UniProtKB.
DR   GO; GO:0010875; P:positive regulation of cholesterol efflux; ISO:RGD.
DR   GO; GO:0032376; P:positive regulation of cholesterol transport; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0045723; P:positive regulation of fatty acid biosynthetic process; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:RGD.
DR   GO; GO:0090108; P:positive regulation of high-density lipoprotein particle assembly; ISO:RGD.
DR   GO; GO:0010884; P:positive regulation of lipid storage; ISO:RGD.
DR   GO; GO:1902895; P:positive regulation of miRNA transcription; ISO:RGD.
DR   GO; GO:0090187; P:positive regulation of pancreatic juice secretion; ISO:RGD.
DR   GO; GO:0051247; P:positive regulation of protein metabolic process; ISO:RGD.
DR   GO; GO:0090340; P:positive regulation of secretion of lysosomal enzymes; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0010867; P:positive regulation of triglyceride biosynthetic process; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0048384; P:retinoic acid receptor signaling pathway; IDA:RGD.
DR   CDD; cd06954; NR_LBD_LXR; 1.
DR   Gene3D; 3.30.50.10; Erythroid Transcription Factor GATA-1, subunit A; 1.
DR   Gene3D; 1.10.565.10; Retinoid X Receptor; 1.
DR   InterPro; IPR023257; Liver_X_rcpt.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR050234; Nuclear_hormone_rcpt_NR1.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   PANTHER; PTHR24082; NUCLEAR HORMONE RECEPTOR; 1.
DR   PANTHER; PTHR24082:SF316; OXYSTEROLS RECEPTOR LXR-BETA; 1.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR02034; LIVERXRECPTR.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF57716; Glucocorticoid receptor-like (DNA-binding domain); 1.
DR   SUPFAM; SSF48508; Nuclear receptor ligand-binding domain; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   2: Evidence at transcript level;
KW   Activator; DNA-binding; Isopeptide bond; Metal-binding; Nucleus; Receptor;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..446
FT                   /note="Oxysterols receptor LXR-beta"
FT                   /id="PRO_0000053534"
FT   DOMAIN          208..446
FT                   /note="NR LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01189"
FT   DNA_BIND        75..152
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         78..98
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         116..140
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   REGION          1..76
FT                   /note="Transactivation AF-1; required for ligand-
FT                   independent transactivation function"
FT                   /evidence="ECO:0000250|UniProtKB:P55055"
FT   REGION          1..69
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          160..201
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          205..446
FT                   /note="Transactivation AF-2; required for ligand-dependent
FT                   transactivation function; mediates interaction with CCAR2"
FT                   /evidence="ECO:0000250|UniProtKB:P55055"
FT   COMPBIAS        1..32
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        55..69
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        179..201
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CROSSLNK        395
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P55055"
FT   CROSSLNK        433
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P55055"
FT   CONFLICT        33
FT                   /note="G -> V (in Ref. 2; AAA52361)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        52..54
FT                   /note="Missing (in Ref. 2; AAA52361)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        219
FT                   /note="A -> V (in Ref. 2; AAA52361)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   446 AA;  49736 MW;  13DF6DC2F0F5FA4D CRC64;
     MSSPTSSLDT PLPGNGSPQP STSSTSPTIK EEGQETDPPP GSEGSSSAYI VVILEPEDEP
     ERKRKKGPAP KMLGHELCRV CGDKASGFHY NVLSCEGCKG FFRRSVVHGG AGRYACRGSG
     TCQMDAFMRR KCQLCRLRKC KEAGMREQCV LSEEQIRKKK IQKQQQQQPP PPTEPASGSS
     ARPAASPGTS EASSQGSGEG EGIQLTAAQE LMIQQLVAAQ LQCNKRSFSD QPKVTPWPLG
     ADPQSRDARQ QRFAHFTELA IISVQEIVDF AKQVPGFLQL GREDQIALLK ASTIEIMLLE
     TARRYNHETE CITFLKDFTY SKDDFHRAGL QVEFINPIFE FSRAMRRLGL DDAEYALLIA
     INIFSADRPN VQEPSRVEAL QQPYVEALLS YTRIKRPQDQ LRFPRMLMKL VSLRTLSSVH
     SEQVFALRLQ DKKLPPLLSE IWDVHE
//
